You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 128 No. 7, July 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  OBSERVATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (16)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Case of Xeroderma Pigmentosum Group A Diagnosed With a Polymerase Chain Reaction (PCR) Technique

Usefulness of PCR in the Detection of Point Mutation in a Patient With a Hereditary Disease

Satoshi Kore-eda, MD; Toshihiro Tanaka, MD, PhD; Shin-ichi Moriwaki, MD; Chikako Nishigori, MD, PhD; Sadao Imamura, MD, PhD

Arch Dermatol. 1992;128(7):971-974.


Abstract

• Background.—
The gene responsible for the xeroderma pigmentosum (XP) group A gene was recently identified and isolated. Preliminary study with fibroblasts from patients with XP group A revealed that most of the Japanese patients with XP group A have a point mutation at the 3' splice acceptor site of intron 3. This mutation site in the XP group A—complementing gene can be recognized by a restriction enzyme, AlwNI. This article describes the usefulness of the polymerase chain reaction diagnosis on XP group A.

Observations.—
We tried a polymerase chain reaction diagnosis on genomic DNA from a sporadic case of XP group A and this child's parents. AlwNI restriction fragment length polymorphism of the polymerase chain reaction product showed three bands for his father's and mother's DNA, one corresponding to normal and two corresponding to a point-mutated gene, respectively. A DNA sample from our patient showed two fragments indicating that only he has the mutated gene.

Conclusions.—
This study demonstrated that we can know that this patient has group A XP without a complementation test that needs a lot of time. Moreover, our study revealed that we can detect the hidden mutated XP group A—complementing gene in the pedigree in which there is no patient with XP. Furthermore, it may be available soon for prenatal diagnosis.

(Arch Dermatol. 1992;128:971-974)



Author Affiliations

From the Department of Dermatology, Faculty of Medicine, Kyoto (Japan) University.


Footnotes

Accepted for publication January 21, 1992.

Reprint requests to Department of Dermatology, Faculty of Medicine, Kyoto University, Shogoin, Sakyo-ku, Kyoto 606, Japan (Dr Tanaka).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Gene Alterations and Clinical Characteristics of Xeroderma Pigmentosum Group A Patients in Japan
Nishigori et al.
Arch Dermatol 1994;130:191-197.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.